NOBEL BIOCARE DANMARK A/S: Financial statements 2013
CVR: 28293364
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 5,277,883 and a net result of DKK 298,710 compared with DKK 408,697 the year before. That is a decrease of 13.2% compared with the year before. Equity in the 2013 report amounted to DKK 1,953,587. The solvency ratio was 38.7%.
- Gross Profit
- DKK 5,277,883
- Profit/Loss
- DKK 298,710
- Equity
- DKK 1,953,587
- Total Assets
- DKK 5,042,505
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 5.3 mio. | 299 t. | 2 mio. | - |
| 2012 | - | 6.1 mio. | 409 t. | 4.7 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
NOBEL BIOCARE DANMARK A/S has published its annual report for 2012. Gross profit came to DKK 6,081,398, and the net result was DKK 408,697.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.